Basic Info
  • Factory Location: Jiangsu

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    EPA can regulate blood lipid metabolism and reduce triglyceride levels in human body. Reduce the risk of cardiovascular disease, and play an effective role in cardiovascular protection. Prevent and improve arteriosclerosis and improve the condition of hypertension. The company has the current internationally independently developed international advanced EPA production line, realizing the whole production process automation, the annual output of 1,000 tons. Advanced and unique domestic production technology to ensure the purity of the product, the relevant substances in the international leading level, the company can also meet the customer requirements in oligomers, plasticizer, PCBs, agricultural residues and other aspects.
Send your message to this supplier
  • From:
  • To:
    Jiangsu Hainekon Biotechnology Company Limited
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service